Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Clal Insurance Enterprises Holdings's earnings per share without non-recurring items for the
three
months ended in Jun. 2026 was ₪7.42.
Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Jun. 2026 was ₪28.64.
During the past 12 months, Clal Insurance Enterprises Holdings's average earnings per share (NRI) Growth Rate was 48.70% per year.
During the past 3 years, the average earnings per share (NRI) Growth Rate was 153.30% per year.
During the past 5 years, the average earnings per share (NRI) Growth Rate was 26.70% per year.
During the past 10 years, the average earnings per share (NRI) Growth Rate was 0.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.
XTAE:CLIS'
s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -55.2 Med: 7.1 Max: 178.6
Current: 153.3
During the past 13 years, Clal Insurance Enterprises Holdings's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 178.60% per year. The lowest was -55.20% per year. And the median was 7.10% per year.
XTAE:CLIS's 3-Year EPS without NRI Growth Rate is ranked better than 96.75% of 400
companies
in the Insurance industry
Industry Median: 16.55
vs XTAE:CLIS: 153.30
Clal Insurance Enterprises Holdings (XTAE:CLIS) EPS without NRI Explanation
EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Clal Insurance Enterprises Holdings EPS without NRI Related Terms
Clal Insurance Enterprises Holdings EPS without NRI Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Clal Insurance Enterprises Holdings EPS without NRI Chart
XTAE:CLIS vs AFL, MET, PRU: EPS without NRI Comparison
For the Insurance - Life subindustry, Clal Insurance Enterprises Holdings's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Clal Insurance Enterprises Holdings PE Ratio without NRI vs Insurance Industry
For the Insurance industry and Financial Services sector, Clal Insurance Enterprises Holdings's PE Ratio without NRI distribution charts can be found below:
* The bar in red indicates where Clal Insurance Enterprises Holdings's PE Ratio without NRI falls into.
Clal Insurance Enterprises Holdings EPS without NRI Calculation
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.
EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₪28.64
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Clal Insurance Enterprises Holdings (XTAE:CLIS) has a EPS without NRI of ₪28.64 as of Jun. 2026. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Clal Insurance Enterprises Holdings and its competitors. According to the industry distribution chart, Clal Insurance Enterprises Holdings ranks #13 out of 400 companies in the Insurance industry, placing it in the top 3.2%.
Is Clal Insurance Enterprises Holdings' EPS without NRI too high?
Clal Insurance Enterprises Holdings' current EPS without NRI is ₪28.64. Based on the distribution chart, Clal Insurance Enterprises Holdings ranks #13 out of 400 companies in the Insurance industry, which is in the top quartile — a strong position relative to peers. Overall, Clal Insurance Enterprises Holdings has a GF Score™ of 72/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Clal Insurance Enterprises Holdings' EPS without NRI compare to AFL and MET?
According to the Insurance industry distribution chart, Clal Insurance Enterprises Holdings ranks #13 out of 400 companies for EPS without NRI. This places Clal Insurance Enterprises Holdings in the top 3% of its industry — outperforming the majority of peers. The industry median EPS without NRI is 16.55. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for an Insurance company?
The median EPS without NRI among Insurance companies is 16.55, based on 400 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Clal Insurance Enterprises Holdings and its competitors. For the Insurance industry, the median EPS without NRI is 16.55 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Clal Insurance Enterprises Holdings's current EPS without NRI is ₪28.64. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Clal Insurance Enterprises Holdings stock overvalued right now?
Based on GuruFocus' analysis, Clal Insurance Enterprises Holdings (XTAE:CLIS) is currently considered Significantly Overvalued. The stock's GF Value™ is ₪121.78, compared to a current price of ₪242.70 — trading 99.3% above its estimated fair value. The current EPS without NRI is ₪28.64. Clal Insurance Enterprises Holdings' overall GF Score™ is 72/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For Clal Insurance Enterprises Holdings (XTAE:CLIS), the current EPS without NRI is ₪28.64 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Clal Insurance Enterprises Holdings (XTAE:CLIS) Overvalued in 2026?
Based on GuruFocus' analysis, Clal Insurance Enterprises Holdings stock appears to be overvalued.
The current stock price of ₪242.70 is trading 99.3% above its estimated GF Value™ of ₪121.78.
GuruFocus considers Clal Insurance Enterprises Holdings to be Significantly Overvalued.
Key valuation signals for XTAE:CLIS:
EPS without NRI: ₪28.64
GF Value™: ₪121.78 vs. price of ₪242.70 (99.3% above fair value)
No single metric tells the full story. See the XTAE:CLIS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Clal Insurance Enterprises Holdings Ltd is an insurance company, part of IDB Group, a conglomerate from Israel. Its lines of business are Nonlife insurance, Health insurance, Pensions, and provident funds for private and corporate clients. Clal insurance divisions are nonlife insurance, long-term savings, and health. The nonlife insurance division offers automotive, property, personal accidents, guarantees, liability, and marine insurance, among others. The life insurance and long-term savings division manages long-term assets, such as life insurance, pensions, and funds. The health insurance division consists of health insurance products, such as local and overseas surgeries, transplants, medications, critical illness, long-term care, and accidents. The company's main market is Israel.
72GF Score
Get the complete analysis for XTAE:CLIS
EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XTAE:CLIS has been successfully added to your 
